Sep 24, 2007 - Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) will move forward with plans to conduct an additional Phase III study evaluating Thelin(tm) (sitaxsentan sodium) in patients with Pulmonary Arterial Hypertension (PAH)... Encysive Pharmaceuticals's Press Release -
Showing posts with label Encysive Pharmaceuticals. Show all posts
Showing posts with label Encysive Pharmaceuticals. Show all posts
Sep 25, 2007
Encysive Pharmaceuticals, Phase III Study With Thelin (Sitaxsentan Sodium) in Pulmonary Arterial Hypertension
Sep 24, 2007 - Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) will move forward with plans to conduct an additional Phase III study evaluating Thelin(tm) (sitaxsentan sodium) in patients with Pulmonary Arterial Hypertension (PAH)... Encysive Pharmaceuticals's Press Release -
Subscribe to:
Comments (Atom)
